文献速递肝病消化道肿瘤与早癌消化内镜

超声质量与肝硬化患者肝细胞癌监测检查性能之间的关联:一项回顾性队列研究

Association between ultrasound quality and test performance for HCC surveillance in patients with cirrhosis: a retrospective cohort study.
PubMed 文献 · Aliment Pharmacol Ther · 2022-02-15

该回顾性队列研究纳入186例肝细胞癌患者和2052例无肝细胞癌的肝硬化患者,评估超声可视化评分与监测检查性能的关联。结果显示,可视化评分C与假阴性风险升高相关(OR 7.94,95%CI 1.23-51.16),敏感性仅27.3%;评分B与假阳性风险升高相关(OR 1.60,95%CI 1.13-2.27)。作者认为超声可视化受损与监测检查性能较差相关,需要替代性的血液生物标志物和影像策略。

要点

  • 可视化评分C与假阴性风险升高相关(OR 7.94,95%CI 1.23-51.16)。
  • 评分A或B的超声敏感性超过75%,评分C仅为27.3%。
  • 评分B与假阳性风险升高相关(OR 1.60,95%CI 1.13-2.27),但所有评分特异性均超过95%。

核心结论

  • 超声可视化受损与监测检查性能较差相关。
  • 对于有超声监测失败风险的患者,需要替代性的血液生物标志物和影像策略。

研究设计与样本

  • 回顾性队列研究,纳入2016年7月至2019年7月在两大型健康系统接受超声监测的肝硬化患者,包括有或无肝细胞癌者。
  • 由解读放射科医生使用超声LI-RADS可视化评分记录超声可视化评估。
  • 采用逻辑回归分析评估超声可视化与诊断检查性能的关联。
  • 在肝细胞癌诊断前一年内进行的超声中评估肝细胞癌检测敏感性,在无肝细胞癌者中评估特异性。
  • 共纳入186例肝细胞癌患者和2052例无肝细胞癌的肝硬化患者。

主要发现

  • 在186例肝细胞癌患者中,肝细胞癌诊断前超声严重受限的可视化(Vis评分C)与假阴性结果风险升高相关,即敏感性较低(OR 7.94,95%CI 1.23-51.16),多变量分析。
  • 可视化评分A或B的超声敏感性超过75%,而可视化评分C仅为27.3%。
  • 在2052例无肝细胞癌的肝硬化患者中,中度可视化受限(Vis评分B)与假阳性结果风险升高相关(OR 1.60,95%CI 1.13-2.27),尽管所有可视化评分的特异性均超过95%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ultrasound visualisation is limited in approximately 20% of patients with cirrhosis undergoing hepatocellular carcinoma (HCC) surveillance; however, it is unknown if impaired visualisation directly impacts test performance. We aimed to evaluate the association between ultrasound visualisation and surveillance test performance. METHODS: We performed a retrospective cohort study among patients with cirrhosis, with or without HCC, who underwent ultrasound-based surveillance at two large health systems between July 2016 and July 2019. Ultrasound visualisation assessment was recorded by interpreting radiologists using the ultrasound LI-RADS Visualisation score. We performed logistic regression analyses to evaluate the association between ultrasound visualisation and diagnostic test performance. We assessed sensitivity for HCC detection among ultrasounds performed in the year prior to HCC diagnoses and specificity using ultrasounds in those without HCC. RESULTS: Among 186 patients with HCC, severely limited visualisation (Vis Score C) on ultrasound prior to HCC diagnosis was associated with increased odds of false-negative results, that is lower sensitivity (OR 7.94, 95% CI 1.23-51.16) in multivariable analysis. Ultrasound sensitivity with visualisation scores A or B exceeded 75%, compared to only 27.3% with visualisation score C. Among 2052 cirrhosis patients without HCC, moderate visualisation limitations (Vis score B) were associated with increased odds of false-positive results (OR 1.60, 1.13-2.27), although specificity exceeded 95% across all visualisation scores. CONCLUSIONS: Impaired ultrasound visualisation is associated with worse surveillance test performance. Alternative blood-based biomarkers and imaging strategies are needed for patients at risk for ultrasound-based surveillance failure.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Chong N, Schoenberger H, Yekkaluri S, et al. Association between ultrasound quality and test performance for HCC surveillance in patients with cirrhosis: a retrospective cohort study. Aliment Pharmacol Ther. 2022. PMID: 35170052. doi:10.1111/apt.16779

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。